Capricor Therapeutics, Inc. (CAPR)
7.83
-0.18
(-2.25%)
USD |
NASDAQ |
Oct 09, 16:00
7.80
-0.03
(-0.38%)
After-Hours: 20:00
Capricor Therapeutics Free Cash Flow (Quarterly) : -37.39M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -37.39M |
| March 31, 2026 | -40.00M |
| December 31, 2025 | -28.69M |
| September 30, 2025 | -23.70M |
| June 30, 2025 | -21.57M |
| March 31, 2025 | -7.574M |
| December 31, 2024 | -15.53M |
| September 30, 2024 | -11.70M |
| June 30, 2024 | -12.37M |
| March 31, 2024 | -1.933M |
| December 31, 2023 | -12.32M |
| September 30, 2023 | -9.427M |
| June 30, 2023 | -9.651M |
| March 31, 2023 | 3.757M |
| December 31, 2022 | -8.125M |
| September 30, 2022 | -6.785M |
| June 30, 2022 | -6.955M |
| March 31, 2022 | 23.42M |
| December 31, 2021 | -5.996M |
| September 30, 2021 | -3.806M |
| June 30, 2021 | -4.837M |
| March 31, 2021 | -3.366M |
| December 31, 2020 | -4.130M |
| September 30, 2020 | -3.130M |
| June 30, 2020 | -2.124M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.218M |
| December 31, 2019 | -1.785M |
| September 30, 2019 | -1.651M |
| June 30, 2019 | -1.777M |
| March 31, 2019 | -1.608M |
| December 31, 2018 | -3.756M |
| September 30, 2018 | -3.128M |
| June 30, 2018 | -3.692M |
| March 31, 2018 | -3.604M |
| December 31, 2017 | -2.667M |
| September 30, 2017 | -3.206M |
| June 30, 2017 | -3.711M |
| March 31, 2017 | -4.679M |
| December 31, 2016 | -4.684M |
| September 30, 2016 | -3.922M |
| June 30, 2016 | -4.915M |
| March 31, 2016 | -4.227M |
| December 31, 2015 | -3.648M |
| September 30, 2015 | -3.930M |
| June 30, 2015 | -3.350M |
| March 31, 2015 | -3.018M |
| December 31, 2014 | -2.885M |
| September 30, 2014 | -2.971M |
| June 30, 2014 | -2.262M |
| March 31, 2014 | 10.40M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| ARS Pharmaceuticals, Inc. | -60.93M |
| SELLAS Life Sciences Group, Inc. | -7.588M |
| Sionna Therapeutics, Inc. | -22.22M |
| Alnylam Pharmaceuticals, Inc. | 292.04M |
| Cytokinetics, Inc. | -164.17M |